Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01335789 · ClinicalTrials.gov registry record · NA
Effect of Oxytocin on Stress in Marijuana Users
A NA study of Marijuana Dependence, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT01335789: Completed NA study of Marijuana Dependence, sponsored by Medical University of South Carolina.
NCT01335789 is a NA study of Marijuana Dependence that has completed, run by Medical University of South Carolina. The registered enrollment target is 16 participants, below the 90-participant average among 6 other Marijuana Dependence trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01335789, a NA study of Marijuana Dependence, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate how people who frequently use marijuana respond to a stressful task, and if a medication (oxytocin) affects this response.
Primary Outcome
Salivary cortisol samples were collected via passive drool to provide empirical assessment of stress reactivity. Reported here is salivary cortisol level 5 minutes following Trier Social Stress Task exposure (approximately 60 minutes post study drug/placebo administration). Trier Social Stress Task is a psychosocial laboratory stress task in which subjects deliver a speech and perform a math problem in front of a stranger audience.
Conditions Studied
Interventions
- DRUG Saline
- DRUG Oxytocin
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2011-03 |
| Est. Completion | 2012-07 |
| Phase | NA |
What the finished NCT01335789 record still lists
NCT01335789 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 90-participant average among 6 other Marijuana Dependence trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Marijuana Dependence appearing as the primary indexed condition, and to 2 interventions - of which Saline is the first listed.
NCT01335789 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT01335789 about?
NCT01335789 is a clinical study titled "Effect of Oxytocin on Stress in Marijuana Users". The purpose of this study is to evaluate how people who frequently use marijuana respond to a stressful task, and if a medication (oxytocin) affects this response.
What is the current status of trial NCT01335789?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2011-03. Estimated completion is 2012-07.
What conditions does trial NCT01335789 study?
This clinical trial studies the following conditions: Marijuana Dependence.
What interventions are being tested in trial NCT01335789?
The interventions under investigation include: Saline (DRUG), Oxytocin (DRUG).
Who is sponsoring clinical trial NCT01335789?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01335789 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Marijuana Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Oxytocin on Craving and Therapy Response
COMPLETED · NA
-
Marijuana Treatment Project 4
COMPLETED · NA
-
Vilazodone Treatment for Marijuana Dependence
COMPLETED · Phase 2
-
Effect of Baclofen on Marijuana Withdrawal and Relapse
COMPLETED · Phase 2
-
Buspirone Treatment for Marijuana Dependence
COMPLETED · Phase 4
-
Effectiveness Study of Dronabinol and BRENDA for the Treatment of Cannabis Withdrawal
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia